Maintenance of remission with human recombinant interferon alfa-2a in patients with stages III and IV low-grade malignant non-Hodgkin's lymphoma. European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group.

Source:http://linkedlifedata.com/resource/pubmed/id/9440721

Download in:

View as

General Info

PMID
9440721